4basebio and Genezen Expand Synthetic DNA Collaboration
CAMBRIDGE, UK and INDIANAPOLIS, IN — August 26, 2026 4basebio PLC and Genezen announced an expanded, non-exclusive strategic collaboration...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CAMBRIDGE, UK and INDIANAPOLIS, IN — August 26, 2026 4basebio PLC and Genezen announced an expanded, non-exclusive strategic collaboration...
